Article
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
Swiss medical weekly - 1 Jan 2010
Gonvers Jean-Jacques, Heim Markus H, Cavassini Matthias, Müllhaupt Beat, Genné Daniel, Bernasconi Enos, Borovicka Jan, Cerny Andreas, Chave Jean-Philippe, Chuard Christian, Dufour François, Dutoit Valérie, Malinverni Raffaelle, Monnat Martine, Negro Francesco, Troilliet Nicolas, Oneta Carl
Abstract excerpt
BACKGROUND/AIMS: Treatment of chronic HCV infection has become a priority in HIV+ patients, given the faster progression to end-stage liver disease. The primary endpoint of this study was to evaluate and compare antiviral efficacy of Peginterferon alpha 2a plus ribavirin in HIV-HCV co-infected and HCV mono-infected patients, and to examine whether 6 months of therapy would have the same efficacy in HIV patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.